New Results
Flipping the odds of drug development success through human genomics
View ORCID ProfileAroon D. Hingorani, View ORCID ProfileValerie Kuan, View ORCID ProfileChris Finan, View ORCID ProfileFelix A. Kruger, View ORCID ProfileAnna Gaulton, Sandesh Chopade, View ORCID ProfileReecha Sofat, Raymond J. MacAllister, View ORCID ProfileJohn P. Overington, View ORCID ProfileHarry Hemingway, View ORCID ProfileSpiros Denaxas, View ORCID ProfileDavid Prieto, View ORCID ProfileJuan Pablo Casas
doi: https://doi.org/10.1101/170142
Aroon D. Hingorani
1Institute of Cardiovascular Science, University College London, London, UK
2Farr Institute of Health Informatics Research in London, Institute of Health Informatics, University College London, UK
Valerie Kuan
1Institute of Cardiovascular Science, University College London, London, UK
2Farr Institute of Health Informatics Research in London, Institute of Health Informatics, University College London, UK
Chris Finan
1Institute of Cardiovascular Science, University College London, London, UK
2Farr Institute of Health Informatics Research in London, Institute of Health Informatics, University College London, UK
Felix A. Kruger
3Benevolent AI, London, UK
Anna Gaulton
4European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Cambridge, UK
Sandesh Chopade
1Institute of Cardiovascular Science, University College London, London, UK
2Farr Institute of Health Informatics Research in London, Institute of Health Informatics, University College London, UK
Reecha Sofat
5Division of Medicine, University College London, London, UK
Raymond J. MacAllister
6Dorset County Hospital NHS Foundation Trust, Dorchester, UK
John P. Overington
1Institute of Cardiovascular Science, University College London, London, UK
7Medicines Discovery Catapult, Mereside, Alderley Park, Alderley Edge, Cheshire, UK
Harry Hemingway
2Farr Institute of Health Informatics Research in London, Institute of Health Informatics, University College London, UK
Spiros Denaxas
2Farr Institute of Health Informatics Research in London, Institute of Health Informatics, University College London, UK
David Prieto
2Farr Institute of Health Informatics Research in London, Institute of Health Informatics, University College London, UK
Juan Pablo Casas
2Farr Institute of Health Informatics Research in London, Institute of Health Informatics, University College London, UK
Article usage
Posted July 30, 2017.
Flipping the odds of drug development success through human genomics
Aroon D. Hingorani, Valerie Kuan, Chris Finan, Felix A. Kruger, Anna Gaulton, Sandesh Chopade, Reecha Sofat, Raymond J. MacAllister, John P. Overington, Harry Hemingway, Spiros Denaxas, David Prieto, Juan Pablo Casas
bioRxiv 170142; doi: https://doi.org/10.1101/170142
Flipping the odds of drug development success through human genomics
Aroon D. Hingorani, Valerie Kuan, Chris Finan, Felix A. Kruger, Anna Gaulton, Sandesh Chopade, Reecha Sofat, Raymond J. MacAllister, John P. Overington, Harry Hemingway, Spiros Denaxas, David Prieto, Juan Pablo Casas
bioRxiv 170142; doi: https://doi.org/10.1101/170142
Subject Area
Subject Areas
- Biochemistry (11715)
- Bioengineering (8723)
- Bioinformatics (29129)
- Biophysics (14936)
- Cancer Biology (12049)
- Cell Biology (17359)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14144)
- Epidemiology (2067)
- Evolutionary Biology (18268)
- Genetics (12221)
- Genomics (16767)
- Immunology (11843)
- Microbiology (28014)
- Molecular Biology (11560)
- Neuroscience (60814)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3231)
- Physiology (4940)
- Plant Biology (10384)
- Synthetic Biology (2878)
- Systems Biology (7333)
- Zoology (1642)